相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer
Radu Pirlog et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer
Hui Yu et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
MiRNAs and Cancer: Key Link in Diagnosis and Therapy
Yu Shi et al.
GENES (2021)
LncRNA CR749391 acts as a tumor suppressor to upregulate KLF6 expression via interacting with miR-181a in gastric cancer
Shengli Shi et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression
Anquan Shang et al.
AGING-US (2020)
Non-Coding RNAs in Lung Tumor Initiation and Progression
Ruben Mercado Santos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy
Chara Papadaki et al.
CANCERS (2020)
Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis
Wei-Xiao Xue et al.
BIOMED RESEARCH INTERNATIONAL (2020)
A panel of miRNAs derived from plasma extracellular vesicles as novel diagnostic biomarkers of lung adenocarcinoma
Bing Yao et al.
FEBS OPEN BIO (2019)
Development of a miRNA-seq based prognostic signature in lung adenocarcinoma
Chathura Siriwardhana et al.
BMC CANCER (2019)
Circulating miRNA panels for specific and early detection in bladder cancer
Wataru Usuba et al.
CANCER SCIENCE (2019)
Therapeutic microRNAs in human cancer
Gizem Ors-Kumoglu et al.
CYTOTECHNOLOGY (2019)
miR-181a/b therapy in lung cancer: reality or myth?
Cornelia Braicu et al.
MOLECULAR ONCOLOGY (2019)
Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2
Lu Chen et al.
ACTA PHARMACEUTICA SINICA B (2019)
BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis
Cong Zhang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
Prognostic value of microRNAs in lung cancer: A systematic review and meta-analysis
Wendi Xiao et al.
MOLECULAR AND CLINICAL ONCOLOGY (2019)
Research progress on the relationship between lung cancer drug-resistance and microRNAs
Xuan Ma et al.
JOURNAL OF CANCER (2019)
MiR-181a contributes gefitinib resistance in non-small cell lung cancer cells by targeting GAS7
Wei Ping et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2
Ming-Jenn Chen et al.
Oncotarget (2018)
A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop
De-Wei Wu et al.
THERANOSTICS (2018)
Identification and Analysis of Human Sex-biased MicroRNAs
Chunmei Cui et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2018)
Identification of biomarker microRNAs for predicting the response colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network
Yaqun Zhu et al.
ONCOTARGET (2017)
miR-181a modulates proliferation, migration and autophagy in AGS gastric cancer cells and downregulates MTMR3
Yong Lin et al.
MOLECULAR MEDICINE REPORTS (2017)
LncRNA SNHG12 contributes to multidrug resistance through activating the MAPK/Slug pathway by sponging miR-181a in non-small cell lung cancer
Pei Wang et al.
ONCOTARGET (2017)
Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance
Chunyu Li et al.
ONCOTARGET (2017)
The Dual Regulatory Role of MiR-181a in Breast Cancer
Chun Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
CircRNA_100269 is downregulated in gastric cancer and suppresses tumor cell growth by targeting miR-630
Yan Zhang et al.
AGING-US (2017)
MiR-630 suppresses breast cancer progression by targeting metadherin
Ci-Xiang Zhou et al.
ONCOTARGET (2016)
MicroRNA-181a regulates epithelial-mesenchymal transition by targeting PTEN in drug-resistant lung adenocarcinoma cells
Haihui Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells
J-X Cao et al.
CELL DEATH & DISEASE (2014)
Decreased serum miR-181a is a potential new tool for breast cancer screening
Li-Juan Guo et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Evaluation of MicroRNA Expression Profiles That May Predict Recurrence of Localized Stage I Non-Small Cell Lung Cancer after Surgical Resection
Santosh K. Patnaik et al.
CANCER RESEARCH (2010)
miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death
Lorenzo Galluzzi et al.
CANCER RESEARCH (2010)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression
Qun Pan et al.
MOLECULAR HUMAN REPRODUCTION (2007)
分享论文
